SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosus: comparative data for New York City and Jefferson County, Alabama, 1956–1965. Arthritis Rheum 1970; 13: 80211.
  • 2
    Fessel WJ. Systemic lupus erythematosus in the community: incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974; 134: 102735.
  • 3
    Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970–1977. Arthritis Rheum 1985; 28: 806.
  • 4
    McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995; 38: 126070.
  • 5
    Samanta A, Roy S, Feehally J, Symmons DP. The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol 1992; 31: 67982.
  • 6
    Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 5518.
  • 7
    Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 45764.
  • 8
    Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002; 3 Suppl 1: S7185.
  • 9
    Sawalha AH, Namjou B, Nath SK, Kilpatrick J, Germundson A, Kelly JA, et al. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. Genes Immun 2002; 3 Suppl 1: S314.
  • 10
    Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22. 3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002; 3 Suppl 1: S5762.
  • 11
    Nath SK, Namjou B, Garriott CP, Frank S, Joslin PA, Kilpatrick J, et al. Linkage analysis of SLE susceptibility: confirmation of SLER1 at 5p15.3. Genes Immun 2004; 5: 20914.
  • 12
    Nath SK, Namjou B, Kilpatrick J, Garriott CP, Bruner GR, Scofield RH, et al. A candidate region on 11p13 for systemic lupus erythematosus: a linkage identified in African-American families. J Investig Dermatol Symp Proc 2004; 9: 647.
  • 13
    Quintero-del-Rio AI, Kelly JA, Garriott CP, Hutchings DC, Frank SG, Aston CE, et al. SLEN2 (2q34-35) and SLEN1 (10q22.3) replication in systemic lupus erythematosus stratified by nephritis. Am J Hum Genet 2004; 75: 3468.
  • 14
    Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15: 4059.
  • 15
    Cooper GS, Dooley MA, Treadwell EL, StClair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus [review]. Arthritis Rheum 1998; 41: 171424.
  • 16
    James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001; 44: 11226.
  • 17
    Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 1992; 57: 19.
  • 18
    Wallace DJ, Quismorio FP Jr. The elusive search for geographic clusters of systemic lupus erythematosus: critical review [review]. Arthritis Rheum 1995; 38: 15647.
  • 19
    Balluz L, Philen R, Ortega L, Rosales C, Brock J, Barr D, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001; 154: 102936.
  • 20
    Clark LC, Giulano A, Walsh B, Guernsey de Zaplen J, Alberts DS, Meister J, et al. The Santa Cruz County Community Health Survey. Phoenix: Arizona Department of Health Services; 1994.
  • 21
    Byers VS, Levin AS, Ozonoff DM, Baldwin RW. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol Immunother 1988; 27: 7781.
  • 22
    Cooper GS, Parks CG, Treadwell EL, StClair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004; 31: 192833.
  • 23
    Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001; 40: 2714.
  • 24
    Czirjak L, Kumanovics G. Exposure to solvents in female patients with scleroderma. Clin Rheumatol 2002; 21: 1148.
  • 25
    Garabrant DH, Lacey JV Jr, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, et al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003; 157: 493500.
  • 26
    Maitre A, Hours M, Bonneterre V, Arnaud J, Arslan MT, Carpentier P, et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 2004; 31: 2395401.
  • 27
    Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S. Occupation, occupational exposure to chemicals and rheumatological disease: a register based cohort study. Scand J Rheumatol 1994; 23: 30510.
  • 28
    Lacey JV Jr, Garabrant DH, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol 1999; 149: 76170.
  • 29
    Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 1995; 134: 15560.
  • 30
    Johansson AS, Stenberg G, Widersten M, Mannervik B. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 1998; 278: 68798.
  • 31
    Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000; 112: 35763.
  • 32
    Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 27580.
  • 33
    Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994; 224: 8939.
  • 34
    Ollikainen T, Hirvonen A, Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ Mol Mutagen 1998; 31: 3115.
  • 35
    Xu X, Wiencke JK, Niu T, Wang M, Watanabe H, Kelsey KT, et al. Benzene exposure, glutathione S-transferase θ homozygous deletion, and sister chromatid exchanges. Am J Ind Med 1998; 33: 15763.
  • 36
    Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis 2005; 26: 8119.
  • 37
    Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005; 26: 395401.
  • 38
    Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001; 11: 75764.
  • 39
    Kang TY, El-Sohemy A, Comelis MC, Eny KM, Bae SC. Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans. Lupus 2005; 14: 3814.
  • 40
    Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK. Polymorphisms in the glutathione S-transferase class μ and θ genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control 1997; 8: 5549.
  • 41
    Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998; 58: 6570.
  • 42
    Park LY, Muscat JE, Kaur T, Schantz SP, Stern JC, Richie JP Jr, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 2000; 10: 12331.
  • 43
    Fraser PA, Ding WZ, Mohseni M, Treadwell EL, Dooley MA, St Clair EW, et al. Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity. J Rheumatol 2003; 30: 27682.
  • 44
    Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum 1982; 25: 5560.
  • 45
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 46
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 47
    Jeffries SK, Choi W, Butler J, Harris KJ, Ahluwalia JS. Strategies for recruiting African-American residents of public housing developments into a randomized controlled trial. Ethn Dis 2005; 15: 7738.
  • 48
    Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz JN, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995; 5: 297302.
  • 49
    Karlson EW, Costenbader KH, McAlindon TE, Massarotti EM, Fitzgerald LM, Jajoo R, et al. High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women. Lupus 2005; 14: 8326.
  • 50
    Cooper GS, Dooley MA, Treadwell EL, StClair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 2001; 28: 26536.
  • 51
    Cooper GS, Dooley MA, Treadwell EL, StClair EW, Gilkeson GS. Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 2002; 55: 9829.
  • 52
    Cooper GS, Dooley MA, Treadwell EL, StClair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case–control study. Arthritis Rheum 2002; 46: 18309.
  • 53
    Cox DR. Regression models and life-tables. J R Stat Soc 1972; B: 187220.
  • 54
    Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 22936.
  • 55
    Faber DR, Krieg EJ. Unequal exposure to ecological hazards: environmental injustices in the Commonwealth of Massachusetts. Environ Health Perspect 2002; 110 Suppl 2: 27788.
  • 56
    Northridge ME, Stover GN, Rosenthal JE, Sherard D. Environmental equity and health: understanding complexity and moving forward. Am J Public Health 2003; 93: 20914.
  • 57
    Chakraborty J. Acute exposure to extremely hazardous substances: an analysis of environmental equity. Risk Anal 2001; 21: 88395.
  • 58
    Soliman MR, Derosa CT, Mielke HW, Bota K. Hazardous wastes, hazardous materials and environmental health inequity. Toxicol Ind Health 1993; 9: 90112.
  • 59
    Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998; 352: 13446.
  • 60
    Bruning T, Lammert M, Kempkes M, Thier R, Golka K, Bolt HM. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol 1997; 71: 5969.
  • 61
    Soderkvist P, Ahmadi A, Akerback A, Axelson O, Flodin U. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scand J Work Environ Health 1996; 22: 3603.
  • 62
    Falck GC, Hirvonen A, Scarpato R, Saarikoski ST, Migliore L, Norppa H. Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutat Res 1999; 441: 22537.
  • 63
    Raza H, Qureshi MM, Montague W. Alteration of glutathione, glutathione S-transferase and lipid peroxidation in mouse skin and extracutaneous tissues after topical application of gasoline. Int J Biochem Cell Biol 1995; 27: 2717.
  • 64
    Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995; 4: 8614.
  • 65
    Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase μ 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994; 15: 107781.
  • 66
    Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 115964.
  • 67
    Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P, et al. Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La− autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 17634.
  • 68
    Mattey DL, Hassell AB, Plant M, Dawes PT, Ollier WR, Jones PW, et al. Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann Rheum Dis 1999; 58: 1648.
  • 69
    Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase θ. Carcinogenesis 1995; 16: 12435.
  • 70
    Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood 1997; 89: 17017.
  • 71
    Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 18791.
  • 72
    Diggle PJ, Chetwynd AG. Second-order analysis of spatial clustering for inhomogeneous populations. Biometrics 1991; 47: 115563.
  • 73
    Ripley BD. The second-order analysis of stationary point processes. J Appl Probab 1976; 13: 25566.
  • 74
    Signorovitch J, Bonetti J, Karlson E, Fraser PA. Time to event analysis in an environmental study of time-varying spatial exposures, with application to the Roxbury Lupus Project. Submitted for publication.
  • 75
    Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, et al. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 2006; 54: 364854.
  • 76
    Massachusetts Department of Environmental Protection. Code of Massachusetts Regulations: Massachusetts Contingency Plan, 310 CMR 40.0000, October 1999.
  • 77
    Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002; 46: 6406.
  • 78
    Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 104460.